Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
The closing price of X4 Pharmaceuticals Inc (NASDAQ: XFOR) was $1.77 for the day, down -8.05% from the previous closing price of $1.92. In other words, the price has decreased by -$8.05 from its previous closing price. On the day, 0.83 million shares were traded. XFOR stock price reached its highest trading level at $1.9 during the session, while it also had its lowest trading level at $1.775.
Ratios:
Our analysis of XFOR’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 3.58 and its Current Ratio is at 3.70. In the meantime, Its Debt-to-Equity ratio is 3.40 whereas as Long-Term Debt/Eq ratio is at 3.35.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, B. Riley Securities on December 12, 2023, Downgraded its rating to Neutral and sets its target price to $1 from $3 previously.
On December 22, 2022, Cantor Fitzgerald started tracking the stock assigning a Overweight rating and target price of $3.Cantor Fitzgerald initiated its Overweight rating on December 22, 2022, with a $3 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on May 16 ’25 when Baldry Mark bought 1,032 shares for $2.48 per share. The transaction valued at 2,561 led to the insider holds 25,337 shares of the business.
Baldry Mark bought 13,404 shares of XFOR for $4,598 on Nov 15 ’24. The Chief Commercial Officer now owns 129,173 shares after completing the transaction at $0.34 per share. On Jan 24 ’25, another insider, Ragan Paula, who serves as the President and CEO of the company, sold 76,473 shares for $0.45 each. As a result, the insider received 34,719 and left with 1,087,386 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, XFOR now has a Market Capitalization of 12706405 and an Enterprise Value of 1335974. As of this moment, X4’s Price-to-Earnings (P/E) ratio for their current fiscal year is 0.79. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.33 while its Price-to-Book (P/B) ratio in mrq is 0.45. Its current Enterprise Value per Revenue stands at 0.043 whereas that against EBITDA is -0.012.
Stock Price History:
The Beta on a monthly basis for XFOR is 0.61, which has changed by -0.9239691 over the last 52 weeks, in comparison to a change of 0.16821623 over the same period for the S&P500. Over the past 52 weeks, XFOR has reached a high of $26.83, while it has fallen to a 52-week low of $1.38. The 50-Day Moving Average of the stock is -28.35%, while the 200-Day Moving Average is calculated to be -82.41%.
Shares Statistics:
XFOR traded an average of 801.10K shares per day over the past three months and 2957320 shares per day over the past ten days. A total of 5.79M shares are outstanding, with a floating share count of 3.84M. Insiders hold about 33.66% of the company’s shares, while institutions hold 31.43% stake in the company. Shares short for XFOR as of 1752537600 were 390377 with a Short Ratio of 0.49, compared to 1749772800 on 484831. Therefore, it implies a Short% of Shares Outstanding of 390377 and a Short% of Float of 5.5.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
